Home Newsfeeds Equillium Q2 EPS $(0.41) Down From $(0.31) YoY

Equillium Q2 EPS $(0.41) Down From $(0.31) YoY

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.41) per share. This is a 32.26 percent decrease over losses of $(0.31) per share from the same period last year.

byMichael Horton

August 15, 2022

1 minute read

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.41) per share. This is a 32.26 percent decrease over losses of $(0.31) per share from the same period last year.

Cowen & Co. Maintains Outperform on UiPath, Lowers Price Target to $20

By Benzinga Newsdesk

September 7, 7:55 AM

Cowen & Co. analyst Bryan Bergin maintains UiPath (NYSE:PATH) with a Outperform and lowers the price target from $27 to $20.

PATH

Macquarie Downgrades News to Neutral, Lowers Price Target to $21.1

By Benzinga Newsdesk

July 28, 9:23 AM

Macquarie analyst Darren Leung downgrades News (NASDAQ:NWSA) from Outperform to Neutral and lowers the price target from $22.3 to $21.1.

NWSA

Retailer Zumiez Stock Falls After Q2 Performance – Revenue Dip, Weak Outlook and More

By Ryan Gustafson

September 7, 5:07 PM

Zumiez Inc. (NASDAQ: ZUMZ) shares are trading lower in Thursday's after-hours session after the company reported second-quarter earnings

ZUMZ

Oppenheimer Holdings Q4 EPS $1.87 Down From $4.61 YoY, Sales $313.58M Down From $365.12M YoY

By Benzinga Newsdesk

January 27, 9:04 AM

Oppenheimer Holdings (NYSE:OPY) reported quarterly earnings of $1.87 per share. This is a 59.44 percent decrease over earnings of $4.61 per share from the same period last year. The company reported $313.58 million in

OPY

Equillium Q2 EPS $(0.41) Down From $(0.31) YoY

Related Posts

Cowen & Co. Maintains Outperform on UiPath, Lowers Price Target to $20

Macquarie Downgrades News to Neutral, Lowers Price Target to $21.1

Retailer Zumiez Stock Falls After Q2 Performance – Revenue Dip, Weak Outlook and More

Oppenheimer Holdings Q4 EPS $1.87 Down From $4.61 YoY, Sales $313.58M Down From $365.12M YoY